SCHEMBL6504520

SCHEMBL6504520

CCOc1ccc(C=CC(=O)N2CCC(C(=O)NC(C)C(=O)O)CC2)c(Cl)c1Cl

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ITGAL P20701 6/20 0.48
ITGB2 P05107 5/20 0.48
ICAM1 P05362 5/20 0.48
CAPN1 P07384 3/20 0.44
KDM4E B2RXH2 1/20 0.43
NPC1 O15118 6/20 0.42
RAB9A P51151 6/20 0.42
SMN1; SMN2 Q16637 4/20 0.42
APOBEC3A P31941 1/20 0.40
APOBEC3G Q9HC16 1/20 0.40
ENPP2 Q13822 2/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
POLB P06746 1/20 0.38
ALDH1A1 P00352 1/20 0.38
GAA P10253 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6504517 1.00 ITGAL (0.48) ITGALITGB2ICAM1CAPN1KDM4E
SCHEMBL8298731 1.00 ITGAL (0.48) ITGALITGB2ICAM1CAPN1KDM4E
SCHEMBL6497345 0.92 KDM4E (0.46) ITGALITGB2ICAM1CAPN1KDM4E
SCHEMBL8297674 0.92 KDM4E (0.46) ITGALITGB2ICAM1CAPN1KDM4E
SCHEMBL6497342 0.92 KDM4E (0.46) ITGALITGB2ICAM1CAPN1KDM4E
SCHEMBL8298381 0.91 ITGAL (0.45) ITGALITGB2ICAM1CAPN1KDM4E
SCHEMBL6497465 0.91 ITGAL (0.45) ITGALITGB2ICAM1CAPN1KDM4E
SCHEMBL6497470 0.91 ITGAL (0.45) ITGALITGB2ICAM1CAPN1KDM4E
SCHEMBL6504728 0.90 ITGAL (0.54) ITGALITGB2ICAM1CAPN1KDM4E
SCHEMBL6504723 0.90 ITGAL (0.54) ITGALITGB2ICAM1CAPN1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005016883-A2 ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-02-24 WO claimed
WO-2005016883-A2 ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-02-24 WO disclosed